• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of July 18, 2012

  • Print
  • Share
  • E-mail

Product Detail

Product Description Nexium (esomeprazole magnesium) Delayed-Release Capsules, 40 mg, 1000-count bottle, Rx only, Manufactured for: AstraZeneca LP, Wilmington, DE 19850; By: AstraZeneca AB, S-151 85 Sodertalje, Sweden, NDC 0186-5040-85, UPC 3 0186-5040-85 0.
Recall Number D-1410-2012
Classification Class III
Code Info Lot #: H008328, Exp 11/14
Product Distributed Qty 2,556 bottles
Reason For Recall Adulterated Presence of Foreign Tablets/Capsules: Some bottles may contain a small number of Nexium 20 mg capsules intended for the Japanese market in addtion to Nexium 40 mg capsules.

Event Detail

Event Id 62439
Product Type Drugs
Status Ongoing
Recalling Firm ASTRA ZENECA Lp
State DE
Country US
Voluntary / Mandated Voluntary: Firm Initiated
Recall Initiation Date 2012-07-02
Initial Firm Notification of Consignee or Public Letter
Distribution Pattern Nationwide.